Industry Standard Research

IPOs in the CRO market remain steady

Monday, April 18, 2016

InVentiv Health has filed paperwork for an initial public offering (IPO) worth up to $100 million, following in the footsteps of three other large private equity-backed CROs that have gone public in recent years. Analysts see strong financial activity on the horizon for the CRO industry.

[Read More]

Survey: Mid-tier CROs shut out of post-marketing

Monday, October 3, 2011

Large CROs garner 57% of the post-marketing studies currently being outsourced, while another 25% of that work is awarded to the few firms that specialize in safety. The remaining 19%? That’s scattered among numerous mid-sized CROs.

[Read More]